COL2A1 Gene Spondyloperipheral dysplasia Genetic Test
At DNA Labs UAE, we offer the COL2A1 Gene Spondyloperipheral dysplasia Genetic Test at a cost of AED 4400.0. This test is designed to diagnose and manage spondyloperipheral dysplasia, a rare genetic disorder that affects the development of the skeleton and peripheral nerves.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Dysmorphology
- Doctor: Pediatrics
- Test Department: Genetics
Pre Test Information
Before undergoing the COL2A1 Gene Spondyloperipheral dysplasia Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the disorder. This will help in understanding the inheritance pattern and identifying potential carriers of the gene mutation.
Test Details
Spondyloperipheral dysplasia is caused by mutations in the COL2A1 gene. Our NGS genetic testing utilizes advanced sequencing technology to analyze multiple genes simultaneously. In the case of spondyloperipheral dysplasia, this test specifically focuses on identifying mutations in the COL2A1 gene responsible for the disorder.
NGS genetic testing is a powerful tool for diagnosing genetic disorders as it can quickly and accurately analyze large amounts of genetic information. It can also provide valuable information about the likelihood of passing on the disorder to future generations, aiding in genetic counseling and family planning.
By offering a comprehensive analysis of the COL2A1 gene and identifying specific mutations, our NGS genetic testing for spondyloperipheral dysplasia can greatly assist in the diagnosis and management of the disorder.
Test Name | COL2A1 Gene Spondyloperipheral dysplasia Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for COL2A1 Gene Spondyloperipheral dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL2A1 Gene Spondyloperipheral dysplasia NGS Genetic DNA Test gene COL2A1 |
Test Details |
Spondyloperipheral dysplasia is a rare genetic disorder that affects the development of the skeleton and peripheral nerves. It is caused by mutations in the COL2A1 gene. NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of spondyloperipheral dysplasia, NGS genetic testing can be used to identify mutations in the COL2A1 gene that are responsible for the disorder. NGS genetic testing is a powerful tool for diagnosing genetic disorders, as it can analyze large amounts of genetic information quickly and accurately. It can also be used to identify carriers of the gene mutation and provide information about the likelihood of passing on the disorder to future generations. Overall, NGS genetic testing for the COL2A1 gene can help in the diagnosis and management of spondyloperipheral dysplasia by providing a comprehensive analysis of the gene and identifying specific mutations that may be causing the disorder. |